The FDA is anticipated to announce its decision on the New Drug Application of the weight management treatment developed by Arena Pharmaceuticals. The drug received a 9-5 vote against its approval by FDA's advisory committee on Sept 16, 2010. The general sentiment is that the drug will NOT receive FDA's nod this time around. However, additional studies are already underway at Arena to shift the focus to diabetes patients. If encouraging results are seen, the company may be able to jump back into the game in late 2011-2012. While shares may seem extremely CHEAP post FDA's decision today, it may still be a while until we see another pop in ARNA's shares due to the expanded timeline for the company's ongoing studies. We may just sit out and watch this time! *FDA is notorious for delaying, so don't be surprised if we don't hear anything concrete today*
 |
| The obese is waiting... |
No comments:
Post a Comment